AN1

0.00%

0.7¢ anagenics limited

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1051

First 1051 Last

Share
Profile

Follow
SprayandWipe

496 Posts.

22

28/04/20

13:15

Post #: 44300848
Share

Originally posted by Immetoday ↑

I'm pretty happy with yesterdays ann's.

Maria didn't get 'some Indian lab test'.......that 'Indian lab test' was actually carried out by an accredited by WHO laboratory and had nothing to do with Cellmid.

There's plenty of info out there at the moment but I've learnt that stories from outlets like New Delhi TV aren't always the best to place your bets on......if you're a fan of their journalistic integrity then that's up to you, I prefer lab reports and detail being provided by people who are in the business.

I'm not expecting anything re tests until Doherty Institute finish their review - I don't know why you'd put something out there until you have the Fed Gov's own funded review as support for your product. From the vast majority of reports I've read Wondfu tests are at the top of the class and so I expect that will be reflected by the Doherty Institute.

My expectation is the next ann will be a ripper and give us a very clear picture of where things are headed on the test front........I'm expecting it will be positive all the way.

Just a note - 12,000 tests have already been commercially sold according to what I've read.....there has been no bad publicity regarding those units in Aus has there? The government (according to the CHO) has 'recently taken delivery' of some antibody tests and are waiting on the remainder of their 1.5 mil they have on order so they can distribute to GP's. (I'm not saying that these are CDY tests but timelines fit)

I've seen tests are quoted at between $20-$30 each.....lets say we average that at $25 x 1.5 mil tests.......$37.5 mil revenue as an initial order........just imagine what that will do to the share price if it was CDY that supplied them.

Don't forget, that's just the initial order.......there is talk of testing all Australians....even with a healthy bulk discount, lets say we sell for $15 each......28 million x $15 - $420 mil....hang on though.....didn't I read everyone will require 2 x tests? ......I'm getting dizzy

Expand

Anyone can throw numbers around, how about these numbers:

Yer dizzying

CDY Price at posting: 21.8¢ Sentiment: Hold Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

WGX

Westgold sets its sights on top five producer status through merger with Karora

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Is oil undervalued?

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GRX

GreenX picks up prospective copper project in Germany

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

There are more pages in this discussion • 220 more messages in this thread...

First 1051 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $3.229M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	197835	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	7500	1

View Market Depth

No.	Vol.	Price($)
2	197835	0.007
4	2016527	0.006
1	300000	0.005
3	600000	0.004
1	600000	0.003

Price($)	Vol.	No.
0.008	7500	1
0.009	280000	1
0.010	157763	1
0.013	750000	1
0.015	340000	2

Last trade - 16.12pm 02/08/2024 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1051

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Is oil undervalued?

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1051

Top Stories

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Is oil undervalued?

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News